| Summary of the company's issued and outstanding public warrants |
| | | | | | | Public | | Private | | | | | | Issued and Outstanding, January 1, 2025 | | — | | 55,403 | Number of warrants issued | | — | | — | Number of warrants exercised | | — | | — | Number of warrants cancelled | | — | | — | Issued and Outstanding, December 31, 2025 | | — | | 55,403 | | | | | | Issued and Outstanding, January 1, 2024 | | 127,778 | | 73,334 | Number of warrants exercised | | (124,897) | | (17,931) | Number of warrants cancelled | | (2,881) | | — | Issued and Outstanding, December 31, 2024 | | — | | 55,403 |
|
| Schedule of issued and outstanding Series A and Series B Warrants |
| | | | | | | Series A | | Series B | | | | | | Issued and Outstanding, January 1, 2025 | | — | | — | Number of warrants issued | | 3,565,245 | | 3,565,245 | Number of warrants exercised | | — | | (3,502,982) | Issued and Outstanding, December 31, 2025 | | 3,565,245 | | 62,263 |
|
| Summary of recurring measurements for assets and liabilities at fair value |
The following details the Company’s recurring measurements for assets and liabilities at fair value on the consolidated balance sheets as of December 31, 2025 (in thousands): | | | | | | | | | | | | | | | | Convertible Notes | | | Warrant Liabilities | | | Contingent Consideration | | | Derivative Liability | | | | (Level 3) | | | (Level 3) | | | (Level 3) | | | (Level 3) | | | | | | | | | | | | | | Balance, January 1, 2025 | | $ | 11,689 | | $ | 1,187 | | $ | 3,541 | | $ | — | Issuance of derivative liability | | | — | | | — | | | — | | | 12,438 | Issuance of warrants | | | — | | | 94,064 | | | — | | | — | Change in fair value | | | 22,911 | | | (84,934) | | | (3,499) | | | 2,441 | Warrant cashless exercise | | | — | | | (7,041) | | | — | | | — | Termination of forward purchase agreements | | | — | | | — | | | — | | | — | Balance, December 31, 2025 | | $ | 34,600 | | $ | 3,276 | | $ | 42 | | $ | 14,879 |
The following details the Company’s recurring measurements for assets and liabilities at fair value on the consolidated balance sheets as of December 31, 2024 (in thousands): | | | | | | | | | | | | | | | | Convertible Notes | | | Warrant Liabilities | | | Contingent Consideration | | | Embedded Forward Purchase Agreement and Make Whole Derivative | | | | (Level 3) | | | (Level 3) | | | (Level 3) | | | (Level 3) | | | | | | | | | | | | | | Balance, January 1, 2024 | | $ | — | | $ | 1,447 | | $ | 104,350 | | $ | 41,043 | Issuance of convertible notes | | | 15,000 | | | — | | | — | | | — | Change in fair value | | | (3,311) | | | 14,719 | | | (100,809) | | | (663) | Warrant cashless exercise | | | — | | | (14,979) | | | — | | | — | Termination of forward purchase agreements | | | — | | | — | | | — | | | (40,380) | Balance, December 31, 2024 | | $ | 11,689 | | $ | 1,187 | | $ | 3,541 | | $ | — |
|